Filing Details

Accession Number:
0001104659-21-093170
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-16 18:29:47
Reporting Period:
2021-07-15
Accepted Time:
2021-07-16 18:29:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1297184 Amphastar Pharmaceuticals Inc. AMPH Pharmaceutical Preparations (2834) 330702205
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1743927 Yakob Liawatidewi C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Evp Corp Admin Center No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-15 23,352 $13.35 77,927 No 4 M Direct
Common Stock Acquisiton 2021-07-15 7,674 $13.03 85,601 No 4 M Direct
Common Stock Disposition 2021-07-15 31,524 $20.01 54,077 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2021-07-15 23,352 $0.00 23,352 $13.35
Common Stock Employee Stock Option (right to buy) Disposition 2021-07-15 7,674 $0.00 7,674 $13.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2027-03-16 No 4 M Direct
36,176 2030-03-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,459 Indirect See footnote
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.80 to $20.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  3. The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
  4. Shares subject to the option are fully vested and immediately exercisable.
  5. Shares subject to the option vest in four equal annual installments beginning on March 16, 2021.